CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Gadoteridol

钆特醇 杂质对照品Gadoteridol Impurities

USP24 个杂质条目24 impurity entries

本页汇总 钆特醇 的 24 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 24 impurity reference standards of Gadoteridol with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 钆特醇(Gadoteridol)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsStability testing of gadoteridol and gadobenate dimeglumine formulations under exposure to high-intensity focused ultrasound
    The British journal of radiology · 2022 · Colombo Serra S et al.  ·  PMID 36169642  ·  DOI
  2. 分析方法Analytical MethodsThe TRUTH confirmed: validation of an intraindividual comparison of gadobutrol and gadoteridol for imaging of glioblastoma using quantitative enhancement analysis
    European radiology experimental · 2021 · Kuhn MJ et al.  ·  PMID 34635965  ·  DOI

钆特醇 —— 原料药与杂质对照品Gadoteridol — drug substance & impurities

共 25 个条目(含原料药本体)25 items incl. the drug substance
Gadoteridol structure
USP原料药 APIAPI
钆特醇Gadoteridol
Gadoteridol
CAS No.120066-54-8
Chemical FormulaC17H29GdN4O7
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 1 (Gadoteridol USP Related Compound A) structure
USPA
钆特醇杂质1 (钆特醇USP相关化合物A)Gadoteridol Impurity 1 (Gadoteridol USP Related Compound A)
Gadoteridol Impurity 1 (Gadoteridol USP Related Compound A)
CAS No.120041-08-9
Chemical FormulaC17H32N4O7
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 1 Calcium Salt (Gadoteridol USP Related Compound A Calcium Salt) (Calteridol Calcium) structure
USPA
钆特醇杂质1 钙盐 (钆特醇USP相关化合物A 钙盐) (卡特利多钙)Gadoteridol Impurity 1 Calcium Salt (Gadoteridol USP Related Compound A Calcium Salt) (Calteridol Calcium)
Gadoteridol Impurity 1 Calcium Salt (Gadoteridol USP Related Compound A Calcium Salt) (Calteridol Calcium)
CAS No.121915-83-1
Chemical Formula2(C17H29N4O73-)·3Ca2+
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 2 structure
2
钆特醇杂质2Gadoteridol Impurity 2
Gadoteridol Impurity 2
CAS No.112188-16-6
Chemical FormulaC14H23N4O63-·Gd3+
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 4 structure
4
钆特醇杂质4Gadoteridol Impurity 4
Gadoteridol Impurity 4
CAS No.2748309-13-7
Chemical FormulaC13H24N4O5
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 5 structure
5
钆特醇杂质5Gadoteridol Impurity 5
Gadoteridol Impurity 5
CAS No.229312-33-8
Chemical FormulaC13H22N4O5
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 11 structure
11
钆特醇杂质11Gadoteridol Impurity 11
Gadoteridol Impurity 11
CAS No.148407-91-4
Chemical FormulaC20H44N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 15 structure
15
钆特醇杂质15Gadoteridol Impurity 15
Gadoteridol Impurity 15
CAS No.114873-52-8
Chemical FormulaC20H38N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 16 structure
16
钆特醇杂质16Gadoteridol Impurity 16
Gadoteridol Impurity 16
CAS No.92943-93-6
Chemical FormulaC16H24N4O84-·Gd3+·H+·C7H17NO5
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 20 structure
20
钆特醇杂质20Gadoteridol Impurity 20
Gadoteridol Impurity 20
CAS No.507475-91-4
Chemical FormulaC20H40N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 21 structure
21
钆特醇杂质21Gadoteridol Impurity 21
Gadoteridol Impurity 21
CAS No.162148-48-3
Chemical FormulaC20H40N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 24 structure
24
钆特醇杂质24Gadoteridol Impurity 24
Gadoteridol Impurity 24
CAS No.137145-75-6
Chemical FormulaC14H30N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 25 structure
25
钆特醇杂质25Gadoteridol Impurity 25
Gadoteridol Impurity 25
CAS No.138884-14-7
Chemical FormulaC17H32N4O7
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 26 structure
26
钆特醇杂质26Gadoteridol Impurity 26
Gadoteridol Impurity 26
CAS No.114873-46-0
Chemical FormulaC16H30N4O7
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 27 structure
27
钆特醇杂质27Gadoteridol Impurity 27
Gadoteridol Impurity 27
CAS No.119895-95-3
Chemical FormulaC16H29N5O8
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 27  Calcium Sodium Salt structure
27
钆特醇杂质27 钙钠盐Gadoteridol Impurity 27 Calcium Sodium Salt
Gadoteridol Impurity 27 Calcium Sodium Salt
CAS No.131410-50-9
Chemical FormulaC16H26N5O83-·Ca2+·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 28 structure
28
钆特醇杂质28Gadoteridol Impurity 28
Gadoteridol Impurity 28
CAS No.137076-43-8
Chemical FormulaC15H26N4O9
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 29 structure
29
钆特醇杂质29Gadoteridol Impurity 29
Gadoteridol Impurity 29
CAS No.1027405-61-3
Chemical FormulaC16H28N4O9
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 31 structure
31
钆特醇杂质31Gadoteridol Impurity 31
Gadoteridol Impurity 31
CAS No.6427-62-9
Chemical FormulaC6H16N6O4
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 36 structure
36
钆特醇杂质36Gadoteridol Impurity 36
Gadoteridol Impurity 36
CAS No.102650-29-3
Chemical FormulaC21H30N4O10
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 37 structure
37
钆特醇杂质37Gadoteridol Impurity 37
Gadoteridol Impurity 37
CAS No.105394-74-9
Chemical FormulaC18H21N3O8S
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 38 structure
38
钆特醇杂质38Gadoteridol Impurity 38
Gadoteridol Impurity 38
CAS No.102650-30-6
Chemical FormulaC22H30N4O10S
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 40 structure
40
钆特醇杂质40Gadoteridol Impurity 40
Gadoteridol Impurity 40
CAS No.173308-18-4
Chemical FormulaC29H54N4O8
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 41 (N1,N2-Diacetylspermine) structure
41
钆特醇杂质41 (N1,N2-二乙酰精胺)Gadoteridol Impurity 41 (N1,N2-Diacetylspermine)
Gadoteridol Impurity 41 (N1,N2-Diacetylspermine)
CAS No.61345-83-3
Chemical FormulaC14H30N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Gadoteridol Impurity 41 Dihydrochloride (N1,N2-Diacetylspermine Dihydrochloride) structure
41
钆特醇杂质41 双盐酸盐 (N1,N2-二乙酰精胺双盐酸盐)Gadoteridol Impurity 41 Dihydrochloride (N1,N2-Diacetylspermine Dihydrochloride)
Gadoteridol Impurity 41 Dihydrochloride (N1,N2-Diacetylspermine Dihydrochloride)
CAS No.77928-71-3
Chemical FormulaC14H30N4O2·2HCl
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

For formulation & analytical R&D

钆特醇 杂质谱研究要点Gadoteridol — impurity profiling notes

下面这些是拿到 钆特醇 的 25 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 25 impurity entries for Gadoteridol, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances